Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gelderblom, Hans"'
Autor:
Lancia, Carlo, Anninga, Jakob K., Sydes, Matthew R., Spitoni, Cristian, Whelan, Jeremy, Hogendoorn, Pancras C.W., Gelderblom, Hans, Fiocco, Marta, Sub Mathematical Modeling, Mathematical Modeling
Publikováno v:
Cancer Chemotherapy and Pharmacology, 83, 951-962
Cancer Chemotherapy and Pharmacology, 83, 5, pp. 951-962
Cancer Chemotherapy and Pharmacology, 83, 951. Springer Verlag
Cancer Chemotherapy and Pharmacology, 83(5), 951-962
Cancer Chemotherapy and Pharmacology, 83, 5, pp. 951-962
Cancer Chemotherapy and Pharmacology, 83, 951. Springer Verlag
Cancer Chemotherapy and Pharmacology, 83(5), 951-962
Purpose: There is lack of consensus on the prognostic value of received high dose intensity in osteosarcoma survivorship. Many studies have not shown a clear survival benefit when dose intensity is increased. The aim of this study is to go beyond che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc27d41c0aea26e45f8561ec58dd4f30
https://hdl.handle.net/1887/121132
https://hdl.handle.net/1887/121132
Autor:
Lunenburg, Carin A T C, Henricks, Linda M, Guchelaar, Henk-Jan, Swen, Jesse J, Deenen, Maarten J, Schellens, Jan H M, Gelderblom, Hans, Sub Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Journal of Cancer, 54, 40-48
European Journal of Cancer, 54, 40. Elsevier Ltd
European Journal of Cancer, 54, 40. Elsevier Ltd
5-Fluorouracil (5-FU) and capecitabine (CAP) are among the most frequently prescribed anticancer drugs. They are inactivated in the liver by the enzyme dihydropyrimidine dehydrogenase (DPD). Up to 5% of the population is DPD deficient and these patie
Autor:
Lunenburg, Carin A T C, Henricks, Linda M, Dreussi, Eva, Peters, Femke P, Fiocco, Marta, Meulendijks, Didier, Toffoli, Giuseppe, Guchelaar, Henk-Jan, Swen, Jesse J, Cecchin, Erika, Schellens, Jan H M, Gelderblom, Hans, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Journal of Cancer, 104, 210. Elsevier Ltd
Background Prospective DPYD genotyping prevents severe fluoropyrimidine (FP)-induced toxicity by decreasing dosages in DPYD variant allele carriers. FP dosages in chemoradiation therapy (CRT) are lower than those in other FP-containing regimens. Phar